Clinical Trials | May 20, 2022
Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics
A primary investment of Rs 194.4 crore has been made
A primary investment of Rs 194.4 crore has been made
This cost-effective tool will be of immense benefit to other high burden countries as well.
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
This new fund is amongst the largest for the sector in India
It is developing the drug candidate to potentially treat immunological diseases
Adynovate in combination with Mypkfit offers personalized treatment and enables HCPs and patients to monitor factor levels from home and help achieve optimum QOL outcomes
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
For the first time in India – fast, precise and efficient calibration of multi-channel micropipettes
India has the second-largest number of adults with diabetes globally, after China
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
Subscribe To Our Newsletter & Stay Updated
